| Identification | Back Directory | [Name]
L-Leucine, L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-α-glutamyl- | [CAS]
126779-13-3 | [Synonyms]
L-Leucine, L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-α-glutamyl- | [Molecular Formula]
C80H129N19O23 | [MOL File]
126779-13-3.mol | [Molecular Weight]
1724.99 |
| Chemical Properties | Back Directory | [Boiling point ]
1984.5±65.0 °C(Predicted) | [density ]
1.270±0.06 g/cm3(Predicted) | [pka]
3.34±0.10(Predicted) | [Sequence]
Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu |
| Hazard Information | Back Directory | [Uses]
Tetanus Toxin (830–844) is a biological active peptide. (tetanus toxin-derived peptide TT830–844 CD4+ T-cell epitope. This promiscuous CD4+ T-cell epitope can bind to a wide range of HLA–DRB molecules and is thus expected to activate CD4+ T-cell responses in a large part of the human population) | [References]
[1] Rosenbaum P, et al. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients. Cancer Immunol Immunother. 2020 May;69(5):703-716. DOI:10.1007/s00262-020-02503-0 |
|
|